# Brii Bio Presents Late-Breaking Data from Its Phase 2 ENRICH and ENHANCE Studies at AASLD 2026, Supporting BRII-179-Based Priming and Enrichment Strategy for HBV Functional Cure

- Source: PR Newswire M&A
- Published: 2026-11-06T00:00:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/brii-bio-presents-late-breaking-data-from-its-phase-2-enrich-and-enhance-studies-at-aasld-2026-supporting-brii-179-based-priming-and-enrichment-strategy-for-hbv-functional-cure-302930553.html
- Canonical: https://groundlevelnews.com/story/brii-bio-presents-late-breaking-data-from-its-phase-2-enrich-and-enhan-d387ac/

Data across five Phase 2 studies of BRII-179, including ENSURE, ENRICH and ENHANCE, support its potential role in priming HBV-specific immune responses and improving functional cure rates with siRNA-based therapies ENRICH prospectively reproduced the BRII-179 priming effect previously...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._